Morgan Adams
Family · Marion, VANPI 1578260824
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$984
- Lilly USA, LLC$777
- AstraZeneca$734
- AbbVie$464
- Otsuka America Pharmaceutical, Inc.$358
- Amgen$312
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 56 | $984 |
| Lilly USA, LLC | 37 | $777 |
| AstraZeneca | 45 | $734 |
| AbbVie | 29 | $464 |
| Otsuka America Pharmaceutical, Inc. | 14 | $358 |
| Amgen | 21 | $312 |
| Boehringer Ingelheim | 11 | $279 |
| Pfizer | 22 | $271 |
| Johnson & Johnson | 16 | $270 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $258 |
| Exact Sciences | 10 | $224 |
| Bayer | 10 | $173 |
| GSK | 8 | $146 |
| Axsome Therapeutics, Inc. | 7 | $136 |
| Merck | 7 | $116 |
| Lundbeck LLC | 5 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $107 |
| Galderma Laboratories, L.p. | 1 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Abbott | 2 | $43 |
| Verona Pharma, Inc. | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Corium, LLC | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
How this compares
$6,179 in reported general payments places this provider in the 95th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,843 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 93 | $951 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $664 |
| Sucralfate | 11 | $633 |
| Cefdinir | 36 | $578 |
| Omeprazole | 41 | $574 |
| Prednisone | 129 | $540 |
| Methylprednisolone | 47 | $403 |
| Doxycycline Hyclate | 40 | $369 |
| Ciprofloxacin Hcl | 53 | $365 |
| Cephalexin | 28 | $185 |
| Azithromycin | 37 | $164 |
| Cyclobenzaprine Hcl | 24 | $156 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $151 |
| Clindamycin Hcl | 19 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $146 | $7,84312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,332 family providers in Virginia.
Other family in Marion
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.